4//SEC Filing
Izumi Raquel E. 4
Accession 0000950170-23-041513
CIK 0001796129other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:27 PM ET
Size
8.0 KB
Accession
0000950170-23-041513
Insider Transaction Report
Form 4
Izumi Raquel E.
DirectorChief Operations Officer10% Owner
Transactions
- Purchase
Common Stock
2023-08-09$0.90/sh+13,036$11,735→ 81,774 total(indirect: By Trust) - Purchase
Common Stock
2023-08-10$0.93/sh+3,440$3,199→ 85,214 total(indirect: By Trust)
Holdings
- 1,618,199
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents a weighted average purchase price. Actual purchase prices ranged from $0.90 to $0.94 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
- [F2]Represents actual price
Documents
Issuer
Vincerx Pharma, Inc.
CIK 0001796129
Entity typeother
Related Parties
1- filerCIK 0001832553
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 6:27 PM ET
- Size
- 8.0 KB